068760.KS · 셀트리온제약
South Korea · RS rating 15 · As of 2026-10-14
| Price | 37,450.00 KRW |
|---|---|
| 1-day change | +0.4% |
| RS rating (overall / 1M / 3M / 12M) | 15 / 31 / 24 / 29 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 27 / 17 / 38 |
| Industry group (rank) | Medical-Generic Drugs (76) |
| EPS growth Q/Q | +55.8% |
| Sales growth Q/Q | +16.0% |
| Distance from 52-week high | +50.5% |
| Market cap (USD) | $1.3B |